Founded in 1994, as one of China’s earliest developed enterprises
in the circle of microbiological in vitro diagnostic reagents,
Encode Medical Engineering Co., Ltd integrates research, production
and sales and is running on a larger scale. Since the very
beginning, Encode is consistently engaged in research and
development of in-vitro diagnostic reagents.
So far we have researched and developed series of microbiological
and immunology reagents, which are used for laboratory diagnosis of
mycoplasma, chlamydia, pneumonia, pathogenic fungus, tuberculosis,
bacterial vaginosis, neisseria gonorrhoeae, etc. The sales network
has covered all over the country.
In 2005, we constructed our study, research & manufacturing
base in Zhuhai, a predominant city of biotech industry in south
China, which covers 15,000m2. The base installed with automatic manufacturing lines including
freeze-dry line and over 2,000m2 standard GMP air-purified workshops makes it definite for company
to develop or larger scale, and with more intensive manufacturing
and high technology.
We obtained ISO9001 & ISO13485 (Especially in Medical Device
Manufacture Management) quality management system verification in
2006. From 2007 to 2009, after the new in-vitro diagnostic reagents
regulations were issued, we successionally passed the rigorous
quality management system evaluation organized by SFDA and GDFDA.
And we also got class 3 certificates for our main
products—Mycoplasma Susceptibility Test Kit, Fungi Susceptibility
Test Kit, Chlamydia Trachomatis Antigen Testing Kit (Colloidal Gold) and M. tuberculosis Antibody (IgG) Testing Kit (Colloidal Gold).
Under industry-study-research” collaboration mode, Encode has
established extensive cooperative ties with Lanzhou University,
South China University of Technology and Jinan University and has
become teaching and practice base of College of Life Science,
Lanzhou University, South China University of Technology and Zhuhai
Encode enjoys a high reputation in this field and has been rated as
one of Guangdong high-tech enterprises and national high-tech
enterprises. Our president Sun Yifeng was elected as vice-chairman
of CACLP and employed as an adjunct Professor of College of Life
Sciences, Lanzhou University in 2008.
The R&D (research and development) center, directly led by the
general manager, with numbers of experts and technicians on
different levels, covers various fields. We are keeping innovating
and improving based on feedbacks from market. We are also
continuously investing in research, developing application scope
& technology level of in-vitro diagnostic reagent in
microbiology, immunology and molecular biology. With financial
support from governments at different levels we have undertaken
four research items (in process) and have been granted the title of
national high-tech enterprise.
Sincerity and harmony are our faith; quality and efficiency are our
targets. Relying on our scientific management, mature marketing
strategy, years of manufacturing experience, good enterprise image
and popular brand, we believe that we will provide you with the
most professional service.